|Integrated genomic analyses of ovarian carcinoma|
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
|Integrated genomic characterization of endometrial carcinoma|
DA Levine, Cancer Genome Atlas Research Network
Nature 497 (7447), 67, 2013
|ARID1A mutations in endometriosis-associated ovarian carcinomas|
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
|Ovarian carcinoma subtypes are different diseases: implications for biomarker studies|
M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ...
PLoS medicine 5 (12), e232, 2008
|Mutation of FOXL2 in granulosa-cell tumors of the ovary|
SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ...
New England Journal of Medicine 360 (26), 2719-2729, 2009
|Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers|
A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ...
New England Journal of Medicine 366 (3), 234-242, 2012
|Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer|
Y Guan, WL Kuo, JL Stilwell, H Takano, AV Lapuk, J Fridlyand, JH Mao, ...
Clinical cancer research 13 (19), 5745-5755, 2007
|Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling|
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
|Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities|
JZ Press, A De Luca, N Boyd, S Young, A Troussard, Y Ridge, P Kaurah, ...
BMC cancer 8 (1), 17, 2008
|Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors|
K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao, CB Gilks, PH Watson, ...
PloS one 4 (7), e6412, 2009
|Differences in tumor type in low-stage versus high-stage ovarian carcinomas|
M Köbel, SE Kalloger, DG Huntsman, JL Santos, KD Swenerton, ...
International Journal of Gynecological Pathology 29 (3), 203-211, 2010
|Quantitative assessment of airway remodeling using high-resolution CT|
Y Nakano, NL Müller, GG King, A Niimi, SE Kalloger, M Mishima, PD Paré
Chest 122 (6), 271S-275S, 2002
|Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell–and patient-derived tumor organoids|
L Huang, A Holtzinger, I Jagan, M BeGora, I Lohse, N Ngai, C Nostro, ...
Nature medicine 21 (11), 1364, 2015
|Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss|
B Clarke, AV Tinker, CH Lee, S Subramanian, M Van De Rijn, D Turbin, ...
Modern Pathology 22 (3), 393, 2009
|Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma|
CB Gilks, DN Ionescu, SE Kalloger, M Köbel, J Irving, B Clarke, J Santos, ...
Human pathology 39 (8), 1239-1251, 2008
|A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary|
M Köbel, SE Kalloger, J Carrick, D Huntsman, H Asad, E Oliva, ...
The American journal of surgical pathology 33 (1), 14-21, 2009
|IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer|
MS Anglesio, J George, H Kulbe, M Friedlander, D Rischin, C Lemech, ...
Clinical cancer research 17 (8), 2538-2548, 2011
|Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas|
KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ...
The Journal of pathology 224 (3), 328-333, 2011
|Genotypic and Phenotypic Diversity of phlD-ContainingPseudomonas Strains Isolated from the Rhizosphere of Wheat|
BBMS Gardener, KL Schroeder, SE Kalloger, JM Raaijmakers, ...
Appl. Environ. Microbiol. 66 (5), 1939-1946, 2000
|HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy|
JN McAlpine, KC Wiegand, R Vang, BM Ronnett, A Adamiak, M Köbel, ...
BMC cancer 9 (1), 433, 2009